A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment

Clinical trial NCT01497041 · UNKNOWN

Trial details

NCT number: NCT01497041
Sponsor: Korean South West Oncology Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Carcinoma, Large Cell

Start date: 2011-02-01
Primary completion: 2013-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.